MedTrace Logo

Mechanisms Behind Antidiabetic Effects by Gastric By-pass

NCT01708096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-03-12

No results posted yet for this study

Summary

The aim of the study is to develop new strategies in treatment of continuous increasing number of patients with type 2 diabetes by understanding how bariatric surgery cures or improves this condition.

Conditions

  • Diabetes Mellitus Typ 2 and Obesity

Interventions

DIETARY_SUPPLEMENT

Modifast

2 weeks before gastric by-pass patients are treated with VLD, 1000 kcal/day

DIETARY_SUPPLEMENT

Normal diet

normal diet 2 weeks before gastric by-pass

Sponsors & Collaborators

Principal Investigators

  • Anders Thorell, Assoc Prof · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01708096 on ClinicalTrials.gov